news_6

Takeda Announces U.S. FDA Breakthrough Therapy Designation Granted for Pevonedistat for the Treatment of Patients with Higher-Risk Myelodysplastic Syndromes (HR-MDS)

– Designation Based on Phase 2 Data and Reinforces Significant Treatment Need for HR-MDS – – Pevonedistat Could be First...

news_6

China AI Report 2020 – Market Overview, Deployments by Sector, Technology & Macro Trends, Case Studies and Key AI Players – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "China AI Report 2020" report has been added to ResearchAndMarkets.com's offering. Leveraging the publisher's unmatched access into China's...

news_6

GL.iNet Launches a Special Edition of the Popular Brume Line on Kickstarter – Introducing Brume-W (GL-MV1000W), a Mini Wireless Gateway for Secure Edge Computing